SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015763
Filing Date
2021-11-12
Accepted
2021-11-12 15:38:40
Documents
14
Period of Report
2021-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20211111x8k.htm   iXBRL 8-K 34783
2 EX-99.1 rsls-20211111xex99d1.htm EX-99.1 306843
3 GRAPHIC rsls-20211111xex99d1001.jpg GRAPHIC 18893
  Complete submission text file 0001558370-21-015763.txt   501230

Data Files

Seq Description Document Type Size
4 EX-101.SCH rsls-20211111.xsd EX-101.SCH 2131
5 EX-101.LAB rsls-20211111_lab.xml EX-101.LAB 15391
6 EX-101.PRE rsls-20211111_pre.xml EX-101.PRE 9927
7 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20211111x8k_htm.xml XML 4721
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 211403009
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences